not tagged
Abbott
[]
the p endpoint, hf at 24 months for mitraclip + gdmt vs. gdmt, was 35.8% vs. 67.9% (hr - 0.53, 95% ,ci: 0.40-0.70, p &lt; 0.001) the primary safety endpoint, freedom from device-related complications at 12 months, was 96.6% for #mitraclip (p &lt; 0.001) #acc23 
Cardiologist FACC, FESC | Physician-scientist | Author | Nature Lover🌳 | #HeartFailure👨🏼‍⚕️| #HFA & #EACVI Committee @escardio | Content Catalyst in @TCTMD